New research covers a 3D OCT foundation model, an OCTA biomarker review and offline smartphone screening for three retinal diseases.
Ophthalmology Times Europe: September/October 2026
A gamified program may speed the brain’s adjustment, new data suggest.
When to retest for inherited retinal dystrophies
Published: | Updated:
João Pedro Marques, MD, PhD, on how systematic reanalysis moved a cohort's solved rate from 59.4% to 70.1% and what it means for gene therapy eligibility
Matias Iglicki, MD, PhD, on patient selection, technical pitfalls and why symmetry decides outcomes in flanged vs sutured fixation
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves subcutaneous Enspryng for TED
2
AAO 2026: Vamikibart shows sustained gains in uveitic macular edema as FDA accepts BLA
3
EC-104 outperforms Ozurdex in phase 2 BETTIS-1 trial for anti-VEGF–resistant DME
4
OT Roundup: Optogenetics Nobel Prize, BRUNELLO, DRAGON, eye transplant
5